Table 3 Multivariable analysis of clinical variables with Cox proportional hazard model for DMFS and OS
Variables | DMFS | OS | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Nodal stage (vs. N0-N1) | NS | NS | ||
First course RT dose (vs. > = 40 Gy) | NS | NS | ||
Chemotherapy regimen (vs. Taxanes-based regimens) | NS | NS | ||
Cisplatin + 5-FU | 1.85 (1.00–3.45) | 0.052 | NS | |
SUVLN | NS | NS | ||
NTR (vs. Low NTR [<= 0.46]) | NS | NS | ||
High NTR (> 0.46) | 1.81 (1.08–3.01) | 0.023** | 1.77 (1.12–2.79) | 0.014** |